Smith MR, Dixon CB, Wang Y, Liu Y, et al. Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-type Non-Small Cell Lung Cancer. Cancer Res 2024 Sep 9. doi: 10.1158/0008-5472.CAN-24-0658.
PMID: 39250241